<!DOCTYPE html>
<html lang="ko">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>RegScan Daily - 2026-02-06</title>
    <style>
        @import url('https://fonts.googleapis.com/css2?family=Noto+Serif+KR:wght@400;600;700&family=Noto+Sans+KR:wght@400;500;600&display=swap');

        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: 'Noto Sans KR', sans-serif;
            background: #f5f5f5;
            color: #1a1a1a;
            line-height: 1.6;
        }

        .wrapper {
            max-width: 720px;
            margin: 0 auto;
            background: #fff;
            min-height: 100vh;
        }

        /* 헤더 */
        header {
            padding: 24px 32px;
            border-bottom: 3px solid #1a1a1a;
        }

        .masthead {
            display: flex;
            justify-content: space-between;
            align-items: baseline;
            margin-bottom: 8px;
        }

        .logo {
            font-family: 'Noto Serif KR', serif;
            font-size: 28px;
            font-weight: 700;
            letter-spacing: -1px;
        }

        .date-area {
            font-size: 13px;
            color: #666;
        }

        .tagline {
            font-size: 12px;
            color: #888;
            letter-spacing: 2px;
            text-transform: uppercase;
        }

        /* 요약 바 */
        .summary-bar {
            display: flex;
            justify-content: space-between;
            padding: 12px 32px;
            background: #fafafa;
            border-bottom: 1px solid #eee;
            font-size: 13px;
        }

        .summary-item {
            display: flex;
            align-items: center;
            gap: 6px;
        }

        .summary-item .num {
            font-weight: 600;
            color: #1a1a1a;
        }

        .summary-item.hot .num {
            color: #c00;
        }

        /* 메인 콘텐츠 */
        main {
            padding: 32px;
        }

        /* 기사 스타일 */
        .article {
            margin-bottom: 32px;
            padding-bottom: 32px;
            border-bottom: 1px solid #eee;
        }

        .article:last-child {
            border-bottom: none;
        }

        .article.main {
            margin-bottom: 40px;
            padding-bottom: 40px;
        }

        .article-meta {
            display: flex;
            gap: 8px;
            margin-bottom: 12px;
        }

        .tag {
            font-size: 11px;
            padding: 3px 8px;
            background: #1a1a1a;
            color: #fff;
            font-weight: 500;
        }

        .tag.hot {
            background: #c00;
        }

        .tag.orphan {
            background: #5a4fcf;
        }

        .tag.fda {
            background: #0066cc;
        }

        .tag.ema {
            background: #cc6600;
        }

        .tag.mfds {
            background: #008844;
        }

        .article-title {
            font-family: 'Noto Serif KR', serif;
            font-size: 24px;
            font-weight: 700;
            line-height: 1.4;
            margin-bottom: 8px;
            letter-spacing: -0.5px;
        }

        .article.main .article-title {
            font-size: 32px;
        }

        .article-subtitle {
            font-size: 15px;
            color: #666;
            margin-bottom: 16px;
        }

        .article-body {
            font-size: 15px;
            line-height: 1.8;
            color: #333;
        }

        .article-body p {
            margin-bottom: 12px;
        }

        .key-points {
            margin: 20px 0;
            padding: 16px 20px;
            background: #f9f9f9;
            border-left: 3px solid #1a1a1a;
        }

        .key-points li {
            margin-bottom: 6px;
            font-size: 14px;
        }

        .medclaim-box {
            margin: 20px 0;
            padding: 16px 20px;
            background: #fff8f0;
            border: 1px solid #f0e0d0;
        }

        .medclaim-box .label {
            font-size: 12px;
            font-weight: 600;
            color: #996633;
            margin-bottom: 8px;
        }

        .medclaim-box .content {
            font-size: 14px;
            color: #664422;
        }

        .price-info {
            display: inline-flex;
            align-items: baseline;
            gap: 4px;
            margin-top: 8px;
            font-size: 13px;
        }

        .price-info .price {
            font-size: 18px;
            font-weight: 600;
            color: #006644;
        }

        /* 기타 승인 목록 */
        .other-section {
            margin-top: 32px;
            padding-top: 24px;
            border-top: 2px solid #1a1a1a;
        }

        .section-title {
            font-family: 'Noto Serif KR', serif;
            font-size: 16px;
            font-weight: 700;
            margin-bottom: 16px;
        }

        .other-table {
            width: 100%;
            font-size: 13px;
            border-collapse: collapse;
        }

        .other-table th {
            text-align: left;
            padding: 8px 0;
            border-bottom: 1px solid #1a1a1a;
            font-weight: 600;
            font-size: 11px;
            text-transform: uppercase;
            letter-spacing: 1px;
            color: #666;
        }

        .other-table td {
            padding: 10px 0;
            border-bottom: 1px solid #eee;
        }

        .other-table .name {
            font-weight: 500;
        }

        .other-table .brand {
            color: #666;
        }

        .other-table .source {
            font-size: 11px;
            font-weight: 600;
        }

        .other-table .date {
            color: #888;
            text-align: right;
        }

        /* 푸터 */
        footer {
            padding: 24px 32px;
            border-top: 1px solid #eee;
            font-size: 11px;
            color: #888;
            text-align: center;
        }

        footer a {
            color: #666;
            text-decoration: none;
        }
    </style>
</head>
<body>
    <div class="wrapper">
        <header>
            <div class="masthead">
                <div class="logo">RegScan</div>
                <div class="date-area">2026년 02월 06일 (금)</div>
            </div>
            <div class="tagline">Global Regulatory Intelligence</div>
        </header>

        <div class="summary-bar">
            <div class="summary-item">
                <span>FDA</span>
                <span class="num">17</span>
            </div>
            <div class="summary-item">
                <span>EMA</span>
                <span class="num">14</span>
            </div>
            <div class="summary-item">
                <span>MFDS</span>
                <span class="num">7</span>
            </div>
            <div class="summary-item hot">
                <span>HOT</span>
                <span class="num">15</span>
            </div>
        </div>

        <main>
            
        <article class="article main">
            <div class="article-meta"><span class="tag hot">HOT</span><span class="tag ema">EMA</span><span class="tag orphan">희귀의약품</span></div>
            <h2 class="article-title">Belumosudil, EMA 승인</h2>
            <p class="article-subtitle">Rezurock · 2026-01-30</p>
            <div class="article-body"></div>
        </article>
    
        <article class="article ">
            <div class="article-meta"><span class="tag hot">HOT</span><span class="tag fda">FDA</span></div>
            <h2 class="article-title">ETANERCEPT 규제 동향 브리핑</h2>
            <p class="article-subtitle">글로벌: FDA | MFDS: 허가 | HIRA: 삭제</p>
            <div class="article-body"><ul class="key-points"><li>FDA 승인</li><li>MFDS 허가</li></ul><p>FDA 승인 (2025-12-10)</p><p>MFDS 허가 완료 (엔브렐주사25밀리그램(에타너셉트,유전자재조합)) | HIRA: deleted | 상한가 ₩nan</p>
                <div class="medclaim-box">
                    <div class="label">메드클레임 시사점</div>
                    <div class="content">비급여 또는 급여 미적용</div>
                    
                </div>
            </div>
        </article>
    
        <article class="article ">
            <div class="article-meta"><span class="tag hot">HOT</span><span class="tag ema">EMA</span></div>
            <h2 class="article-title">DASATINIB 규제 동향 브리핑</h2>
            <p class="article-subtitle">글로벌: FDA | MFDS: 허가 | HIRA: 급여 (₩44,497)</p>
            <div class="article-body"><ul class="key-points"><li>FDA 승인</li><li>MFDS 허가</li><li>주요 질환 치료제</li></ul><p>FDA 승인 (2010-07-28)</p><p>MFDS 허가 완료 (스프라이셀정70밀리그램(다사티닙)) | HIRA: reimbursed | 상한가 ₩44,497</p>
                <div class="medclaim-box">
                    <div class="label">메드클레임 시사점</div>
                    <div class="content">건강보험 급여 적용 중</div>
                    <div class="price-info">상한가 <span class="price">₩44,497</span></div>
                </div>
            </div>
        </article>
    
        <article class="article ">
            <div class="article-meta"><span class="tag hot">HOT</span><span class="tag ema">EMA</span></div>
            <h2 class="article-title">DULAGLUTIDE 규제 동향 브리핑</h2>
            <p class="article-subtitle">글로벌: FDA+EMA | MFDS: 허가 | HIRA: 급여 (₩30,666)</p>
            <div class="article-body"><ul class="key-points"><li>FDA 승인</li><li>EMA 승인</li><li>MFDS 허가</li><li>3개국 승인</li></ul><p>FDA 승인 (2025-05-28), EMA 승인 (2014-11-21)</p><p>MFDS 허가 완료 (트루리시티 0.75밀리그램/0.5밀리리터(둘라글루타이드,유전자재조합) 일회용 펜) | HIRA: reimbursed | 상한가 ₩30,666</p>
                <div class="medclaim-box">
                    <div class="label">메드클레임 시사점</div>
                    <div class="content">건강보험 급여 적용 중</div>
                    <div class="price-info">상한가 <span class="price">₩30,666</span></div>
                </div>
            </div>
        </article>
    

            
            <div class="other-section">
                <h3 class="section-title">Other Approvals</h3>
                <table class="other-table">
                    <thead>
                        <tr>
                            <th>성분명</th>
                            <th>제품명</th>
                            <th>출처</th>
                            <th style="text-align:right">승인일</th>
                        </tr>
                    </thead>
                    <tbody>
                        
                <tr>
                    <td class="name">PRIMAQUINE PHOSPHATE</td>
                    <td class="brand">PRIMAQUINE PHOSPHATE</td>
                    <td class="source">FDA</td>
                    <td class="date">01/23</td>
                </tr>
            
                <tr>
                    <td class="name">ARSENIC TRIOXIDE</td>
                    <td class="brand">ARSENIC TRIOXIDE</td>
                    <td class="source">FDA</td>
                    <td class="date">10/15</td>
                </tr>
            
                <tr>
                    <td class="name">SELADELPAR LYSINE</td>
                    <td class="brand">LIVDELZI</td>
                    <td class="source">FDA</td>
                    <td class="date">08/14</td>
                </tr>
            
                <tr>
                    <td class="name">OLANZAPINE</td>
                    <td class="brand">ZYPREXA</td>
                    <td class="source">FDA</td>
                    <td class="date">09/30</td>
                </tr>
            
                <tr>
                    <td class="name">OLANZAPINE</td>
                    <td class="brand">ZYPREXA ZYDIS</td>
                    <td class="source">FDA</td>
                    <td class="date">04/06</td>
                </tr>
            
                <tr>
                    <td class="name">OLANZAPINE PAMOATE</td>
                    <td class="brand">ZYPREXA RELPREVV</td>
                    <td class="source">FDA</td>
                    <td class="date">12/11</td>
                </tr>
            
                <tr>
                    <td class="name">METHYLPHENIDATE HYDROCHLORIDE</td>
                    <td class="brand">CONCERTA</td>
                    <td class="source">FDA</td>
                    <td class="date">08/01</td>
                </tr>
            
                <tr>
                    <td class="name">OLANZAPINE AND SAMIDORPHAN L-MALATE</td>
                    <td class="brand">LYBALVI</td>
                    <td class="source">FDA</td>
                    <td class="date">05/28</td>
                </tr>
            
                <tr>
                    <td class="name">AMOXICILLIN AND CLAVULANATE POTASSIUM</td>
                    <td class="brand">AMOXICILLIN AND CLAVULANATE POTASSIUM</td>
                    <td class="source">FDA</td>
                    <td class="date">11/09</td>
                </tr>
            
                <tr>
                    <td class="name">AMLODIPINE</td>
                    <td class="brand">NORLIQVA</td>
                    <td class="source">FDA</td>
                    <td class="date">02/24</td>
                </tr>
            
                <tr>
                    <td class="name">DAPTOMYCIN</td>
                    <td class="brand">DAPTOMYCIN</td>
                    <td class="source">FDA</td>
                    <td class="date">06/29</td>
                </tr>
            
                <tr>
                    <td class="name">WATER</td>
                    <td class="brand">PUR-WASH</td>
                    <td class="source">FDA</td>
                    <td class="date">09/01</td>
                </tr>
            
                <tr>
                    <td class="name">ORAL SEMAGLUTIDE</td>
                    <td class="brand">RYBELSUS</td>
                    <td class="source">FDA</td>
                    <td class="date">09/20</td>
                </tr>
            
                <tr>
                    <td class="name">VENLAFAXINE HYDROCHLORIDE</td>
                    <td class="brand">VENLAFAXINE HYDROCHLORIDE</td>
                    <td class="source">FDA</td>
                    <td class="date">11/23</td>
                </tr>
            
                <tr>
                    <td class="name">OLANZAPINE</td>
                    <td class="brand">ZYPREXA INTRAMUSCULAR</td>
                    <td class="source">FDA</td>
                    <td class="date">03/29</td>
                </tr>
            
                <tr>
                    <td class="name">CETIRIZINE HCL</td>
                    <td class="brand">CETIRIZINE HCL</td>
                    <td class="source">FDA</td>
                    <td class="date">07/23</td>
                </tr>
            
                <tr>
                    <td class="name">eltrombopag</td>
                    <td class="brand">Eltrombopag Viatris</td>
                    <td class="source">EMA</td>
                    <td class="date">12/12</td>
                </tr>
            
                <tr>
                    <td class="name">deferasirox</td>
                    <td class="brand">Exjade</td>
                    <td class="source">EMA</td>
                    <td class="date">08/28</td>
                </tr>
            
                <tr>
                    <td class="name">quizartinib</td>
                    <td class="brand">Vanflyta</td>
                    <td class="source">EMA</td>
                    <td class="date">11/06</td>
                </tr>
            
                <tr>
                    <td class="name">adalimumab</td>
                    <td class="brand">Yuflyma</td>
                    <td class="source">EMA</td>
                    <td class="date">02/11</td>
                </tr>
            
                <tr>
                    <td class="name">travoprost;timolol</td>
                    <td class="brand">DuoTrav</td>
                    <td class="source">EMA</td>
                    <td class="date">04/23</td>
                </tr>
            
                <tr>
                    <td class="name">sugammadex</td>
                    <td class="brand">Sugammadex Amomed</td>
                    <td class="source">EMA</td>
                    <td class="date">01/10</td>
                </tr>
            
                <tr>
                    <td class="name">fingolimod</td>
                    <td class="brand">Gilenya</td>
                    <td class="source">EMA</td>
                    <td class="date">03/17</td>
                </tr>
            
                <tr>
                    <td class="name">ustekinumab</td>
                    <td class="brand">Uzpruvo</td>
                    <td class="source">EMA</td>
                    <td class="date">01/05</td>
                </tr>
            
                <tr>
                    <td class="name">trastuzumab</td>
                    <td class="brand">Trazimera</td>
                    <td class="source">EMA</td>
                    <td class="date">07/26</td>
                </tr>
            
                <tr>
                    <td class="name">gallium (68Ga) chloride;germanium (68Ge) chloride</td>
                    <td class="brand">GalliaPharm</td>
                    <td class="source">EMA</td>
                    <td class="date">08/01</td>
                </tr>
            
                <tr>
                    <td class="name">flutemetamol (18F)</td>
                    <td class="brand">Vizamyl</td>
                    <td class="source">EMA</td>
                    <td class="date">08/22</td>
                </tr>
            
                <tr>
                    <td class="name">Pranlukast Hydrate</td>
                    <td class="brand">씨투케어정50밀리그램(프란루카스트수화물)</td>
                    <td class="source">MFDS</td>
                    <td class="date">01/30</td>
                </tr>
            
                <tr>
                    <td class="name">Lactulose Concentrate Solution</td>
                    <td class="brand">락토락시럽(락툴로오스농축액)</td>
                    <td class="source">MFDS</td>
                    <td class="date">01/30</td>
                </tr>
            
                <tr>
                    <td class="name">Doxylamine Succinate</td>
                    <td class="brand">쿨드림롱정(독시라민숙신산염)</td>
                    <td class="source">MFDS</td>
                    <td class="date">01/30</td>
                </tr>
            
                <tr>
                    <td class="name">Amlodipine Besylate/Chlorthalidone/Telmisartan</td>
                    <td class="brand">텔미트리플정80/5/25밀리그램(텔미사르탄,암로디핀,클로르탈리돈)</td>
                    <td class="source">MFDS</td>
                    <td class="date">01/30</td>
                </tr>
            
                <tr>
                    <td class="name">Amlodipine Besylate/Chlorthalidone/Telmisartan</td>
                    <td class="brand">텔미트리플정80/5/12.5밀리그램(텔미사르탄,암로디핀,클로르탈리돈)</td>
                    <td class="source">MFDS</td>
                    <td class="date">01/30</td>
                </tr>
            
                <tr>
                    <td class="name">Amlodipine Besylate/Chlorthalidone/Telmisartan</td>
                    <td class="brand">텔미트리플정40/5/12.5밀리그램(텔미사르탄,암로디핀,클로르탈리돈)</td>
                    <td class="source">MFDS</td>
                    <td class="date">01/30</td>
                </tr>
            
                <tr>
                    <td class="name">Tofacitinib Citrate</td>
                    <td class="brand">토마토정10밀리그램(토파시티닙시트르산염)</td>
                    <td class="source">MFDS</td>
                    <td class="date">02/02</td>
                </tr>
            
                    </tbody>
                </table>
            </div>
            
        </main>

        <footer>
            <p>RegScan AI · Scanning Global Regulation into Local Impact</p>
            <p>Generated 2026-02-06 14:10</p>
        </footer>
    </div>
</body>
</html>
